2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
5948
Pancreatic Neoplasms
3563
Carcinoma, Hepatocellular
3273
Stomach Neoplasms
3057
Colonic Neoplasms
2328
Rectal Neoplasms
2192
Esophageal Neoplasms
1801
Liver Neoplasms
1247
Neoplasms
1181
Breast Neoplasms
1064
Neoplasm Metastasis
871
Carcinoma, Non-Small-Cell Lung
794
Lung Neoplasms
745
Cholangiocarcinoma
743
Gastrointestinal Neoplasms
662
Ovarian Neoplasms
630
Esophageal Squamous Cell Carcinoma
585
Prostatic Neoplasms
485
Melanoma
457
Biliary Tract Neoplasms
441
Head and Neck Neoplasms
376
Uterine Cervical Neoplasms
344
Carcinoma, Renal Cell
329
Gastrointestinal Stromal Tumors
326
Adenocarcinoma Of Esophagus
315
Sarcoma
304
Barrett Esophagus
300
Anus Neoplasms
284
Gallbladder Neoplasms
283
Endometrial Neoplasms
281
Interventions
toripalimab
2
Oxaliplatin
2
Capecitabine
2
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Early Low Rectal Cancer
×
Gastrointestinal
×
Clear all
NCT05555888
2025-01-15
TORCH-E
Fudan University
Phase 2
Recruiting
34 enrolled
NCT06462053
2024-06-17
TORCH-E2
Fudan University
Phase 2
Recruiting
134 enrolled